Therapeutic and diagnostic challenges for frontotemporal dementia
In the search for therapeutic modifiers, frontotemporal dementia (FTD) has traditionally been overshadowed by other conditions such as Alzheimer’s disease. A clinically and pathologically diverse condition, FTD has been galvanized by a number of recent discoveries such as novel genetic variants in...
Main Authors: | Simon eD'Alton, Jada eLewis |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2014-08-01
|
Series: | Frontiers in Aging Neuroscience |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fnagi.2014.00204/full |
Similar Items
-
Valosin-containing protein Asp395Gly mutation in a patient with frontotemporal dementia: a case report
by: Ryota Kobayashi, et al.
Published: (2022-11-01) -
Experimental Disease-Modifying Agents for Frontotemporal Lobar Degeneration
by: Giunta M, et al.
Published: (2021-03-01) -
Neuropathology of frontotemporal lobar degeneration: A review
by: Valéria Santoro Bahia, et al. -
Molecular Pathways Involved in Frontotemporal Lobar Degeneration with TDP-43 Proteinopathy: What Can We Learn from Proteomics?
by: Merel O. Mol, et al.
Published: (2021-09-01) -
Proteomics of the dentate gyrus reveals semantic dementia specific molecular pathology
by: Merel O. Mol, et al.
Published: (2022-12-01)